Effect / research focus
Combined online around growth-hormone signalling. The blend is unapproved, with unconfirmed safety and benefit.
Back to the peptide atlas
Blends & catalogue termsNon-standardised blendNot FDA/EMA approved
CJC-1295 no DAC + Ipamorelin
Non-standardised combination targeting GHRH and ghrelin-receptor signalling
Also known as: CJC no DAC + IPA · Mod GRF + Ipamorelin
How communities discuss it
Discussed in online communities in relation to the research focus described above. Anecdotes are not evidence of efficacy and are not use instructions.
Community reports are anecdotes, not evidence of efficacy or safety.
Why there is no mixing guide here
Reconstitution depends on the exact approved product, its official label and medical supervision. With unapproved substances, identity, concentration, sterility and stability are often unknown. A universal step-by-step guide would therefore be unsafe.
Primary sources
The linked regulator and trial-register sources support the current status summary.